Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMOs) globally. The company provides comprehensive design, development, and manufacturing services to multinational medical device original equipment manufacturers (OEMs). Integer derives its revenue from three principal product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets (which includes advanced surgical, orthopedics, and portable medical devices). Its specialized product portfolio includes components for implantable pacemakers, cardioverter defibrillators, spinal cord stimulators, catheters, and proprietary medical batteries. The company operates a global manufacturing and R&D footprint with facilities across the United States, Ireland, Switzerland, Mexico, Uruguay, Malaysia, and the Dominican Republic. By focusing on high-growth medtech markets and leveraging its deep expertise in precision manufacturing, clinical-grade quality, and regulatory compliance, Integer maintains a strong competitive position as an essential supply chain partner for the world's leading healthcare companies.
